Harmony Biosciences (NASDAQ:HRMY – Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.60 by $0.07, Yahoo Finance reports. Harmony Biosciences had a net margin of 22.16% and a return on equity of 27.49%. The business had revenue of $154.62 million […]
Harmony Biosciences (NASDAQ:HRMY) Releases Quarterly Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Needham & Company LLC in a research report issued on Tuesday, Benzinga reports. They currently have a $50.00 price target on the stock. Needham & Company LLC’s price target suggests a potential upside of 70.94% from the stock’s […]
Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare Epilepsy tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.